Therapeutic effect of hyperbaric oxygen on inclusion body myositis
Abbreviated Journal Title
Undersea Hyperb. Med.
Keywords
ENDOPLASMIC-RETICULUM STRESS; PROTEASOME INHIBITION; MUSCLE-FIBERS; PILOT TRIAL; TNF-ALPHA; MACROPHAGES; SECRETION; AUTOPHAGY; EXPOSURE; DISEASE; Marine & Freshwater Biology; Medicine, Research & Experimental
Abstract
An inflammatory myopathy, inclusion body myositis (IBM) presents with progressive muscle weakness against a background of elevated creatine kinase and diffuse endomysial damage. Typically occurring in patients greater than 50 years of age, it is commonly misdiagnosed as polymyositis or other rheumatological disease and is often ineffectively treated with steroids [1]. The approach to IBM is frequently a clinical challenge due to its unique and often aberrant response to common treatment modalities. Here we report an apparent improvement in the clinical course of and associated laboratory findings in a patient with co-existing IBM following the use of hyperbaric oxygen therapy as an adjunct for managing ischemic colitis.
Journal Title
Undersea and Hyperbaric Medicine
Volume
39
Issue/Number
6
Publication Date
1-1-2012
Document Type
Article
Language
English
First Page
1111
Last Page
1114
WOS Identifier
ISSN
1066-2936
Recommended Citation
"Therapeutic effect of hyperbaric oxygen on inclusion body myositis" (2012). Faculty Bibliography 2010s. 3131.
https://stars.library.ucf.edu/facultybib2010/3131
Accessibility Statement
This item was created or digitized prior to April 24, 2027, or is a reproduction of legacy media created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the University Libraries provides accessible versions of archival materials upon request. To request an accommodation for this item, please submit an accessibility request form.
Comments
Authors: contact us about adding a copy of your work at [email protected]